We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Feather Safety Razor

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Novel Point-of-Care Device Helps Diagnose Osteoporosis

By HospiMedica International staff writers
Posted on 01 Feb 2017
Print article
Image: The Bindex osteoporosis screening and diagnostics device (Photo courtesy of Bone Index).
Image: The Bindex osteoporosis screening and diagnostics device (Photo courtesy of Bone Index).
A novel portable bone density scanner detects osteoporosis with 90% sensitivity and specificity, helping physicians arrive at an accurate diagnosis.

The Bindex is a pocket-sized tool for osteoporosis screening and diagnostics that provides bone density measurements comparable to those of standard axial dual-energy X-ray absorptiometry (DXA). It works by measuring the cortical thickness of the tibia; the results, when combined with other patient data, are used to estimate the hip region’s bone mineral density, a parameter usually received via DXA devices used in hospitals. The Bindex can replace nearly 70% of DXA scans for patients under osteoporosis suspicion, with only 30% of patients requiring a subsequent full DXA scan.

The device measures cortical bone thickness in just 30 seconds, providing immediate warning signs of osteoporosis, and allowing medical decisions to be made without delay. Once the measurement has been made, the Bindex is connected to a laptop or desktop computer via USB for graphical display of the results. The Bindex device is a product of Bone Index, and has been approved by the U.S. Food and Drug Administration (FDA).

“Undiagnosed osteoporosis is a worldwide challenge; in the US alone osteoporosis is responsible for two million broken bones every year, costing over 19 billion dollars,” said Ossi Riekkinen, PhD, CEO of Bone Index. “One of the biggest challenges is the limited availability of osteoporosis diagnostics, since bone density scans are mostly performed in hospitals with large DXA X-ray machines that entail high costs. This is why Bindex is a game-changer.”

Osteoporosis is defined as a bone density of 2.5 standard deviations below that of a young adult, as measured by DXA. It is the most common reason for a broken bone among the elderly, and may be due to a lower than normal peak bone mass and a greater than normal bone loss. It is more common in women than men, with 2-8% of males and 9-38% of females affected after menopause, usually due to lower levels of estrogen.


Print article

Channels

Surgical Techniques

view channel
Image: Novel surface treatment could prevent deadly hospital infections without antibiotics (Photo courtesy of Penn State)

Novel Surface Treatment Stops Microbes from Adhering to Medical Devices

Hospitals and medical clinics can be the source of nasty infections, resulting in death from infection-related complications and billions in direct medical costs. The biggest culprits, experts say - accounting... Read more

Patient Care

view channel
Image: Future wearable health tech could measure gases released from skin (Photo courtesy of Pexels)

Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases

Most research on measuring human biomarkers, which are measures of a body’s health, rely on electrical signals to sense the chemicals excreted in sweat. But sensors that rely on perspiration often require... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.